This $6.5 Million Healthcare Trim Comes Amid a 71% Stock Surge and 20% Revenue Growth [Yahoo! Finance]
Axogen, Inc. (AXGN)
Last axogen, inc. earnings: 2/24 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.axogeninc.com
Company Research
Source: Yahoo! Finance
the fourth quarter, an estimated $6.53 million trade based on quarterly average pricing, according to a February 17, 2026, SEC filing. What happened According to a SEC filing dated February 17, 2026, DAFNA Capital Management reduced its position in Axogen (NASDAQ:AXGN) by 265,456 shares during the fourth quarter of 2025. The estimated transaction value of the sale is $6.53 million, calculated using the average closing price for the quarter. The fund finished the period with 476,826 shares of Axogen, worth $15.61 million at quarter end. What else to know After the sale, Axogen represents 3.63% of the fund's 13F reportable assets under management. Top holdings after the filing include: NASDAQ:RVMD: $48.15 million (11.33% of AUM) NYSEMKT:XBI: $41.03 million (9.65% of AUM) NYSEMKT:STXS: $31.47 million (7.40% of AUM) NASDAQ:ATRC: $23.63 million (5.56% of AUM) NASDAQ:CYTK: $23.57 million (5.55% of AUM) As of Friday, AXGN shares were priced at $30.78, up 71% over the pa
Show less
Read more
Impact Snapshot
Event Time:
AXGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXGN alerts
High impacting Axogen, Inc. news events
Weekly update
A roundup of the hottest topics
AXGN
News
- Axogen Insider Sale of 5,221 Shares Follows 20% Revenue Growth in 2025. Here's What to Know [Yahoo! Finance]Yahoo! Finance
- AxoGen Says BLA Approval Secures Avance Use, Boosts Coverage Talks and Reimbursement Momentum [Yahoo! Finance]Yahoo! Finance
- AxoGen Touts FDA BLA Win, Targets 18% Growth and Wider Nerve Repair Adoption at Raymond James Conference [Yahoo! Finance]Yahoo! Finance
- AxoGen, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- A Look At Axogen (AXGN) Valuation After Recent Share Price Pullback And BLA Expectations [Yahoo! Finance]Yahoo! Finance
AXGN
Earnings
- 2/24/26 - Beat
AXGN
Sec Filings
- 3/18/26 - Form 4
- 3/18/26 - Form 4
- 3/2/26 - Form 4
- AXGN's page on the SEC website